Nguyen Thi Hien Hau

Nguyen Thi Hien Hau

Auto-generated profile, based on publicly available information

Nguyen Thi Hien Hau

Duy Tan University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Reviews in Medical Virology
Verified
Journal Article
Closed access
TLTrang Le
Trang Le
TVTamilarasy Vasanthakumaran
Tamilarasy Vasanthakumaran
HHHau Nguyen Thi Hien
Hau Nguyen Thi Hien
IHI‐Chun Hung
I‐Chun Hung
MLMai Ngoc Luu
Mai Ngoc Luu
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy

1 February 2023 in Human Antibodies
Verified
Journal Article
Open access
PDF file
PTPhu Tv
Phu Tv
TTThu Thao Tran
Thu Thao Tran
HHHuynh Trung Hao
Huynh Trung Hao
NHNguyen Thi Hien Hau
Nguyen Thi Hien Hau
Nityanand JainNityanand Jain
Nityanand Jain
ARAigars Reinis
Aigars Reinis
BACKGROUND: Postural Orthostatic Tachycardia Syndrome (POTS) is a common condition affecting more than 170 people per 100,000 population. However, POTS following COVID-19 vaccination remains a rare reporting in the medical literature. OBJECTIVE: We, herein, summarize and highlight the evidence that has been reported regarding POTS-like symptoms following COVID-19 vaccination. METHODS: We conducted a literature search and summarized the findings in the form of a narrative commentary. All types of publications (case reports/series, original articles, letters to editors, brief communications etc.) in English language were included. RESULTS: Whilst the exact pathogenetic mechanism behind POTS is yet to elucidated, there has been increasing evidence pointing towards an autoimmune dysfunction. Females were found to be predominantly affected (72%) with age range from 17 years to 52 years. Additionally, it seems that POTS-like symptoms could be triggered after immunization with Pfizer- BioNTech, Moderna, and Oxford-AstraZeneca COVID-19 vaccines. The symptoms typically appear within the first week, depending upon previous exposure to the virus and presence of other systemic conditions. In some patients, the condition is self-resolving. However, in others, non-pharmacological interventions coupled with negative ionotropic medications can be used for symptomatic management of the patients. CONCLUSIONS: Timely diagnosis and proper treatment are quintessential for ensuring early alleviation (and in some cases complete resolution) of symptoms. Furthermore, there may be episodes of relapse. Overall prognosis of the new-onset POTS-like symptoms is difficult to predict based on current literature.

13 October 2022 in Current Medical Research and Opinion
Verified
Journal Article
Open access
Abdelrahman ElsayidAbdelrahman Elsayid
Abdelrahman Elsayid
VTVan Phu Tran
Van Phu Tran
RERanda Elsheikh
Randa Elsheikh
NHNguyen Thi Hien Hau
Nguyen Thi Hien Hau
SGSiti Mariam Abd Gani
Siti Mariam Abd Gani
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
The factors associated with hesitancy in receiving the COVID-19 vaccines have been widely examined by several studies worldwide. Although individual attitude plays a significant role in vaccine uptake, the WHO and public health experts believe that tackling the spread of COVID-19 is only achievable by guaranteeing vaccine equity across the globe, especially in low-and-middle-income countries, where the vaccination process is being hindered by other factors besides vaccine hesitancy. Among these factors is the refusal of the AstraZeneca vaccine because of its short shelf life. Therefore, we aimed in this letter to propose some solutions that may contribute to solving this specific problem.